LAKE
FOREST, Calif., May 4, 2023
/PRNewswire/ -- BIOLASE, Inc. (NASDAQ: BIOL), the global leader in
dental lasers, today announced that it will release first quarter
2023 financial and operating results on Thursday, May 11, 2023, after the close of the
U.S. financial markets and will host a conference call and webcast
that day at 4:30 p.m. ET /
1:30 p.m. PT to discuss the results
and corporate developments.
To access the live call, dial 877-545-0523 (U.S.) or +1
973-528-0016 (International) and provide the following access code:
180082.
A live and archived webcast of the conference call will be
accessible on the BIOLASE Investor Relations Page. In addition, a
phone replay will be available approximately two hours following
the end of the call, and it will remain available for one week. To
access the call replay, dial 877-481-4010 or +1 919-882-2331
(International) and enter replay passcode 48342.
About BIOLASE
BIOLASE is a medical device company
that develops, manufactures, markets, and sells laser systems in
dentistry and medicine. BIOLASE's products advance the practice of
dentistry and medicine for patients and healthcare professionals.
BIOLASE's proprietary laser products incorporate approximately 259
actively patented and 24 patent-pending technologies designed to
provide biologically and clinically superior performance with less
pain and faster recovery times. BIOLASE's innovative products
provide cutting-edge technology at competitive prices to deliver
superior results for dentists and patients. BIOLASE's principal
products are dental laser systems that perform a broad range of
dental procedures, including cosmetic and complex surgical
applications. From 1998 through December 31,
2022, BIOLASE has sold over 45,500 laser systems in over 80
countries around the world. Laser products under development
address BIOLASE's core dental market and other adjacent medical and
consumer applications.
For updates and information on Waterlase iPlus®,
Waterlase Express™, and laser dentistry,
find BIOLASE online at
www.biolase.com, Facebook at www.facebook.com/biolase,
Twitter at www.twitter.com/biolaseinc, Instagram at
www.instagram.com/waterlase_laserdentistry, and LinkedIn
at www.linkedin.com/company/biolase.
BIOLASE®, Waterlase® and Waterlase
iPlus® are registered trademarks of BIOLASE,
Inc.
Contacts:
EVC Group, Inc.
Michael Polyviou/Todd Kehrli
(732) 232-6914
mpolyviou@evcgroup.com; tkehrli@evcgroup.com
View original content to download
multimedia:https://www.prnewswire.com/news-releases/biolase-to-report-first-quarter-2023-results-on-may-11-2023-301816574.html
SOURCE BIOLASE, Inc.